Targeting Wnt/β-catenin signaling enhances the efficacy of anti-CD38 immunotherapy in multiple myeloma

Background: Previous studies have shown that the Wnt/β-catenin signaling pathway is aberrantly activated in multiple myeloma (MM) and regulates the growth of MM cells, while recent studies reported crosstalk between Wnt and STAT3 signaling in various non-MM systems. In addition, it has been shown th...

Descripción completa

Detalles Bibliográficos

Autores principales:	Heng Li, Yunguang Chen, Michaela Gregorova, Tingting Yang, Xiayi Zhang, Xiaoyu Yu, Zhen Wang, Haiying Hua, Long Ye, Xiaowei Qi, Marcel Spaargaren, Steven T. Pals, Zemin Ren
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Elsevier 2025-12-01
Colección:	Neoplasia: An International Journal for Oncology Research
Materias:	Multiple myeloma Wnt/β-catenin STAT3 pathway CD38 Daratumumab
Acceso en línea:	http://www.sciencedirect.com/science/article/pii/S1476558625001228
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!